Showing results (81-90 of 371) with videos related to

Sort By:
Pageof 38
Blood Reviews|May 2, 2016
Myeloid-derived suppressor cells: The green light for myeloma immune escapeEhsan Malek, Marcos de Lima, John J Letterio, et al.
Bone Marrow Transplantation|July 25, 2018
Methods to prevent and treat relapse after hematopoietic stem cell transplantation with tyrosine kinase inhibitors, immunomodulating drugs, deacetylase inhibitors, and hypomethylating agentsYi-Bin Chen, Philip L McCarthy, Theresa Hahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 15, 2011
Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placementHassan Khan, Shilpa Oberoi, Armeen Mahvash, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2009
Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials NetworkPamala A Jacobson, Jiayin Huang, Juan Wu, et al.
Cancer|February 4, 2006
Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myelomaMuzaffar H Qazilbash, Rima Saliba, Marcos De Lima, et al.
Haematologica|February 27, 2025
Maintenance therapy with oral decitabine plus cedazuridine after allogeneic stem cell transplantation for myelodysplastic syndromePortia Smallbone, Terri Lynn Shigle, Oren Paslovsky, et al.
Leukemia & Lymphoma|May 27, 2004
High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myelomaMichele L Donato, Ana Aleman, Richard E Champlin, et al.
Leukemia & Lymphoma|June 14, 2003
Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximabRaymond Wong, Marcos de Lima, Daniel Couriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2020
Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System AnalysisAvirup Guha, Daniel Addison, Prantesh Jain, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2010
Lymphocyte recovery predicts outcomes in cord blood and T cell-depleted haploidentical stem cell transplantationStefan O Ciurea, Victor Mulanovich, Ying Jiang, et al.
Pageof 38